After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, DAWN falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Day One Biopharmaceuticals Inc is $878.75M. A total of 0.9 million shares were traded on the day, compared to an average of 1.17M shares.
In the most recent transaction, York Charles N II sold 4,370 shares of DAWN for 11.96 per share on Feb 18 ’25. After the transaction, the COO, CFO AND SECRETARY now owns 252,638 company shares. In a previous transaction on Feb 18 ’25, Dubow Adam sold 4,646 shares at 11.96 per share. DAWN shares that GENERAL COUNSEL owns now total 39,602.
Among the insiders who sold shares, Bender Jeremy disposed of 12,048 shares on Feb 18 ’25 at a per-share price of $11.96. This resulted in the CHIEF EXECUTIVE OFFICER holding 128,015 shares of DAWN after the transaction. In another insider transaction, ADAM DUBOW bought 4,646 shares at $11.96 per share on Feb 18 ’25.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, DAWN has a high of $18.07 and a low of $7.88.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. DAWN’s latest balance sheet shows that the firm has $284.31M in Cash & Short Term Investments as of fiscal 2021. There were $220.00k in debt and $8.66M in liabilities at the time. Its Book Value Per Share was $4.97, while its Total Shareholder’s Equity was $281.15M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DAWN is Buy with a score of 4.70.
